Wilson Martin 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Sep 9, 2025
Insider Transaction Report
Form 4
Wilson Martin
General Counsel
Transactions
- Award
Common Stock
2025-09-08+150,000→ 285,462 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on September 8, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.